The COVID-19 pandemic has put research evidence and its use in health policymaking under a new spotlight. Faced with the need for immediate action, as most recently shown with vaccination roll-out strategies, many politicians and other leaders have publicly stressed the need to follow the ‘science’. Scientific advisors and advisory bodies have gained unprecedented visibility. At the same time, the conflicts between researchers/health experts and political decision-makers have, now and then, been vividly brought to the fore. (…) More than ever before, countries need to counter misinformation and rapidly mobilise the best available evidence, and present it in userfriendly ways to decision-makers.
Please read the commentary published in the BMJ GH.
